Dr. Kuo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 S San Mateo Dr
San Mateo, CA 94401Phone+1 650-696-5420
Summary
- "Dr. Eric Kuo is a dedicated and compassionate oncologist committed to providing exceptional care to his patients. With a strong emphasis on patient-centered decision-making, Dr. Kuo ensures that each treatment plan is tailored to meet the unique needs and preferences of his patients. His thoughtful approach to care is complemented by his active involvement in oncology research, where he continually seeks to advance the field and improve patient outcomes. Known for his kindness and diligence, Dr. Kuo is deeply respected by both his patients and colleagues for his unwavering commitment to excellence in medical care."
Education & Training
Stanford Health CareFellowship, Hematology and Medical Oncology, 2021 - 2024
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2018 - 2021
University of Texas Southwestern Medical SchoolClass of 2018, MD, Distinction in Quality Improvement and Patient Safety
Rice UniversityBA, Biochemistry and Cell Biology, 2010 - 2014- Rice UniversityMinor, Global Health Technologies, 2010 - 2014
Certifications & Licensure
CA State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsOlder Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.Catherine Lai, Rahul S Bhansali, Eric J Kuo, Gabriel Mannis, Richard J Lin
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2023-05-01 - 1 citationsNeurotoxicity with blinatumomab in combination with intrathecal methotrexate therapy.Sandy On, Eric Kuo, Kimberly M Lau
Leukemia & Lymphoma. 2023-01-01 - 26 citationsConcordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia.Lori Muffly, Vandana Sundaram, Connie Chen, Ilana R. Yurkiewicz, Eric Kuo
Blood Advances. 2021-08-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
